STOCK TITAN

Omada Health (OMDA) CAO exercises options, sells 1,042 shares at $25

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Omada Health, Inc. insider Craig Gracey, Chief Accounting Officer, exercised stock options for 1,042 shares of common stock on August 10, 2026 at an exercise price of $6.57 per share. On the same date, 1,042 common shares were sold at $25.00 per share pursuant to a Rule 10b5-1 trading plan. Following the option exercise, 32,292 option shares remained outstanding and directly held.

Positive

  • None.

Negative

  • None.
Insider Gracey Craig
Role Chief Accounting Officer
Sold 1,042 shs ($26K)
Approx. gross sale proceeds $26K
Approx. exercise cost $7K
Approx. pre-tax spread $19K
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) F1, F2 1,042 $0.00 $0.00
Exercise Common Stock F1 1,042 $6.57 $7K
Sale Common Stock F1 1,042 $25.00 $26K
Holdings After Transaction: Stock Option (Right to Buy) — 32,292 shares (Direct); Common Stock — 15,441 shares (Direct)
Footnotes (2)
  1. F1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.
  2. F2. 25% of the shares subject to the option vest on the first anniversary measured from September 9, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
Options exercised 1,042 shares Stock options for common stock exercised on August 10, 2026
Exercise price $6.57 per share Exercise price of stock option converted into common stock
Shares sold 1,042 shares Common stock sale on August 10, 2026
Sale price $25.00 per share Per-share price for common stock sale
Options remaining 32,292 shares Total shares underlying options directly held after the exercise
Option expiration October 23, 2034 Expiration date of the reported stock option award
10b5-1 plan adoption date March 13, 2026 Date Craig Gracey adopted the Rule 10b5-1 trading plan
Rule 10b5-1 trading plan regulatory
"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
Vesting Commencement Date financial
"25% of the shares subject to the option vest on the first anniversary"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
Exercise or conversion of derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
Common Stock financial
"underlying_security_title: Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

What insider transaction did Omada Health (OMDA) report for Craig Gracey?

Omada Health reported that Chief Accounting Officer Craig Gracey exercised options for 1,042 shares at $6.57 per share and sold 1,042 common shares at $25.00 per share on August 10, 2026.

Was the Omada Health (OMDA) insider trade made under a Rule 10b5-1 plan?

Yes. The transactions were made pursuant to a Rule 10b5-1 trading plan adopted by Craig Gracey on March 13, 2026, indicating the trades were pre-arranged rather than discretionary on the trade date.

What option terms applied to Craig Gracey’s Omada Health (OMDA) stock options?

The exercised stock option had an exercise price of $6.57 per share and an expiration date of October 23, 2034. After the reported exercise, 32,292 option shares remained directly held by Craig Gracey.

At what price did the Omada Health (OMDA) insider sell common stock?

On August 10, 2026, Craig Gracey sold 1,042 shares of Omada Health common stock at a price of $25.00 per share, in a transaction coded as a sale of non-derivative securities.

How many Omada Health (OMDA) options does Craig Gracey hold after this Form 4?

After the reported option exercise, Craig Gracey directly held 32,292 shares subject to stock options. This figure relates specifically to the option award referenced in the filing’s derivative transaction table.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Gracey Craig

(Last)(First)(Middle)
C/O OMADA HEALTH, INC.
611 GATEWAY BLVD, SUITE 120

(Street)
SOUTH SAN FRANCISCO CALIFORNIA 94080

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Accounting Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/10/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/10/2026M(1)1,042A$6.5716,483D
Common Stock08/10/2026S(1)1,042D$2515,441D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$6.5708/10/2026M(1)1,042 (2)10/23/2034Common Stock1,042$032,292D
Explanation of Responses:
1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.
2. 25% of the shares subject to the option vest on the first anniversary measured from September 9, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
/s/ Nathan Salha, as Attorney-in-Fact for Craig Gracey08/12/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)